Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 14, 2014 - Issue 8
Submit an article Journal homepage
915
Views
14
CrossRef citations to date
0
Altmetric
Drug Evaluations

Liraglutide in the treatment of obesity

Sarah Yoon Ai NgUniversity of Liverpool, Aintree University Hospitals NHS Foundation Trust, Clinical Sciences Centre, Department of Diabetes and Endocrinology, Longmoor Lane, Liverpool L9 7AL, UK
&
John P H WildingUniversity of Liverpool, Aintree University Hospitals NHS Foundation Trust, Clinical Sciences Centre, Department of Diabetes and Endocrinology, Longmoor Lane, Liverpool L9 7AL, UK+44 151 529 5885; +44 151 529 5888; [email protected]
Pages 1215-1224 | Published online: 06 Jun 2014

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Aneta Myšková, David Sýkora, Jaroslav Kuneš & Lenka Maletínská. (2023) Lipidization as a tool toward peptide therapeutics. Drug Delivery 30:1.
Read now
Chen-Hsiu Lin, Li Shao, Yu-Mei Zhang, Yu-Ju Tu, Yuzhen Zhang, Brian Tomlinson, Paul Chan & Zhongmin Liu. (2020) An evaluation of liraglutide including its efficacy and safety for the treatment of obesity. Expert Opinion on Pharmacotherapy 21:3, pages 275-285.
Read now

Articles from other publishers (12)

Alejandra Cornejo-Estrada, Carlos Nieto-Rodríguez, Darwin A. León-Figueroa, Emilly Moreno-Ramos, Cielo Cabanillas-Ramirez & Joshuan J. Barboza. (2023) Efficacy of Liraglutide in Obesity in Children and Adolescents: Systematic Review and Meta-Analysis of Randomized Controlled Trials. Children 10:2, pages 208.
Crossref
Xueying Chen, Xiaoying He, Yan Guo, Liehua Liu, Hai Li, Jinfu Tan, Weidong Feng, Hongyu Guan, Xiaopei Cao, Haipeng Xiao & Yanbing Li. (2021) Glucose‐dependent insulinotropic polypeptide modifies adipose plasticity and promotes beige adipogenesis of human omental adipose‐derived stem cells. The FASEB Journal 35:5.
Crossref
Alison Maunder, Erica Bessell, Romy Lauche, Jon Adams, Amanda Sainsbury & Nicholas R. Fuller. (2020) Effectiveness of herbal medicines for weight loss: A systematic review and meta‐analysis of randomized controlled trials. Diabetes, Obesity and Metabolism 22:6, pages 891-903.
Crossref
Yongmei Li, Jianying Du, Endong Zhu, Juanjuan Zhang, Jie Han, Wei Zhao, Bei Sun & Derun Tian. (2018) Liraglutide suppresses proliferation and induces adipogenic differentiation of 3T3-L1 cells via the Hippo-YAP signaling pathway. Molecular Medicine Reports.
Crossref
Michelle L. Johnson, M. Jill Saffrey & Victoria J. Taylor. (2017) Glucagon-like peptide-1 (GLP-1) increases in plasma and colon tissue prior to estrus and circulating levels change with increasing age in reproductively competent Wistar rats. Peptides 90, pages 55-62.
Crossref
Jana Zemenová, David Sýkora, Lenka Maletínská & Jaroslav Kuneš. (2017) Lipopeptides as therapeutics: applications and in vivo quantitative analysis . Bioanalysis 9:2, pages 215-230.
Crossref
R. Kumar, D. M. Kerins & T. Walther. (2016) Cardiovascular safety of anti-diabetic drugs. European Heart Journal - Cardiovascular Pharmacotherapy 2:1, pages 32-43.
Crossref
Jonathan R. S. Arch. (2015) Horizons in the Pharmacotherapy of Obesity. Current Obesity Reports 4:4, pages 451-459.
Crossref
Aline Haas de Mello, Morgana Prá, Larissa Colonetti Cardoso, Rosiane de Bona Schraiber & Gislaine Tezza Rezin. (2015) Incretin-based therapies for obesity treatment. Metabolism 64:9, pages 967-981.
Crossref
Robert H. Howland. (2015) Melatonin, Liraglutide, and Naltrexone/Bupropion for the Treatment of Obesity and Medication-Related Weight Gain. Journal of Psychosocial Nursing and Mental Health Services 53:6, pages 19-22.
Crossref
Hermann Toplak, Euan Woodward, Volkan Yumuk, Jean-Michel Oppert, Jason C.G. Halford & Gema Frühbeck. (2015) 2014 EASO Position Statement on the Use of Anti-Obesity Drugs. Obesity Facts 8:3, pages 166-174.
Crossref
Alexander T El Gammal. (2014) Obesity research: Status quo and future outlooks. World Journal of Translational Medicine 3:3, pages 119.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.